Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study

Yumiko Tatsukawa; Masataka Tsuge; Yoshiiku Kawakami; Yuichi Hiyama; Eisuke Murakami; Mio Kurihara; Motonobu Nomura; Ken Tsushima; Takuro Uchida; Takashi Nakahara; Daiki Miki; Tomokazu Kawaoka; Hiromi Abe-Chayama; Michio Imamura; Hiroshi Aikata; Hidenori Ochi; C Nelson Hayes; Hiroiku Kawakami; Kazuaki Chayama

doi:10.3851/IMP3289

Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study

Antivir Ther. 2019;23(8):709. doi: 10.3851/IMP3289.

Authors

Yumiko Tatsukawa^{1

2}, Masataka Tsuge^{1

2

3}, Yoshiiku Kawakami^{1

2}, Yuichi Hiyama¹, Eisuke Murakami^{1

2}, Mio Kurihara^{1

2}, Motonobu Nomura^{1

2}, Ken Tsushima^{1

2}, Takuro Uchida^{1

2}, Takashi Nakahara^{1

2}, Daiki Miki^{1

2

4}, Tomokazu Kawaoka^{1

2}, Hiromi Abe-Chayama^{1

2}, Michio Imamura^{1

2}, Hiroshi Aikata^{1

2}, Hidenori Ochi^{1

2

4}, C Nelson Hayes^{1

2}, Hiroiku Kawakami⁵, Kazuaki Chayama^{1

2

4}

Affiliations

¹ Department of Gastroenterology and Metabolism, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
² Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
³ Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.
⁴ Laboratory for Digestive Diseases, Center for Genomic Medicine, The Institute of Physical and Chemical Research (RIKEN), Hiroshima, Japan.
⁵ Kawakami Clinic, Hiroshima, Japan.

PMID: 30632982
DOI: 10.3851/IMP3289

No abstract available

Publication types

Published Erratum